D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+2.79%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$65B
AUM Growth
+$3.69B
Cap. Flow
+$1,000M
Cap. Flow %
1.54%
Top 10 Hldgs %
11.94%
Holding
2,887
New
293
Increased
1,088
Reduced
1,108
Closed
240

Sector Composition

1 Technology 19.2%
2 Consumer Discretionary 16.83%
3 Healthcare 16.01%
4 Industrials 8.99%
5 Financials 8.91%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RACE icon
2576
Ferrari
RACE
$85.4B
0
RDHL
2577
Redhill Biopharma
RDHL
$3.26M
-14
Closed -$113K
RES icon
2578
RPC Inc
RES
$1.01B
-60,454
Closed -$690K
RKDA icon
2579
Arcadia Biosciences
RKDA
$4.35M
-266
Closed -$74K
RLI icon
2580
RLI Corp
RLI
$6.16B
-15,418
Closed -$553K
RNAC icon
2581
Cartesian Therapeutics
RNAC
$262M
-1,022
Closed -$73K
RNR icon
2582
RenaissanceRe
RNR
$11.2B
-1,800
Closed -$258K
RUN icon
2583
Sunrun
RUN
$3.7B
-54,852
Closed -$771K
SAGE
2584
DELISTED
Sage Therapeutics
SAGE
0
SBS icon
2585
Sabesp
SBS
$15.6B
-218,257
Closed -$2.31M
SGMO icon
2586
Sangamo Therapeutics
SGMO
$157M
-179,575
Closed -$1.71M
SHEN icon
2587
Shenandoah Telecom
SHEN
$748M
-9,485
Closed -$421K
SID icon
2588
Companhia Siderúrgica Nacional
SID
$1.99B
-18,102
Closed -$74K
SIRI icon
2589
SiriusXM
SIRI
$8.17B
-14,930
Closed -$846K
SKX icon
2590
Skechers
SKX
$9.51B
-31,485
Closed -$1.06M
SNCR icon
2591
Synchronoss Technologies
SNCR
$65.4M
-2,178
Closed -$119K
SQM icon
2592
Sociedad Química y Minera de Chile
SQM
$11.8B
0
SRI icon
2593
Stoneridge
SRI
$230M
-6,961
Closed -$201K
SSP icon
2594
E.W. Scripps
SSP
$260M
-138,000
Closed -$2.9M
SSSS icon
2595
SuRo Capital
SSSS
$208M
-19,719
Closed -$125K
STAA icon
2596
STAAR Surgical
STAA
$1.37B
-15,662
Closed -$535K
STE icon
2597
Steris
STE
$24.5B
0
SVRA icon
2598
Savara
SVRA
$660M
-38,075
Closed -$281K
SXI icon
2599
Standex International
SXI
$2.41B
-5,760
Closed -$423K
TAC icon
2600
TransAlta
TAC
$3.66B
-110,200
Closed -$810K